Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease

Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease

Intracranial atherosclerotic disease (ICAD) has been characterized by the degree of arterial stenosis and downstream hypoperfusion, yet microscopic derangements of endothelial shear stress at the luminal wall may be key determinants of plaque growth, vascular remodeling and thrombosis that culminate...

Full description

Bibliographic Details
Main Authors:	David S. Liebeskind, Jason D. Hinman, Naoki Kaneko, Hiroaki Kitajima, Tristan Honda, Adam H. De Havenon, Edward Feldmann, Raul G. Nogueira, Shyam Prabhakaran, Jose G. Romano, Peter W. Callas, David J. Schneider
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Neurology
Subjects:	intracranial atherosclerosis stroke shear stress FcγRIIa receptor platelet activation and reactivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.646309/full

Similar Items

Association between FCγ RIIA polymorphism and brucellosis
by: M. Asmar, et al.
Published: (2007-01-01)

Association of FCγRIIA (CD32) polymorphism with susceptibility to brucellosis
by: Zahra Hosseini khah, et al.
Published: (2014-08-01)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
by: Gilles Thibault, et al.
Published: (2021-06-01)

Plasma levels of the soluble form of the FcγRIIa receptor vary with receptor polymorphisms and are elevated in rheumatoid arthritis
by: Jianlin Qiao, et al.
Published: (2020-04-01)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
by: Bruce D. Wines, et al.
Published: (2021-10-01)

Mucor circinelloides induces platelet aggregation through integrin αIIbβ3 and FcγRIIA
by: Harlene Ghuman, et al.
Published: (2019-02-01)

Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
by: Sokratis A. Apostolidis, et al.
Published: (2022-03-01)

Cytoskeleton Dependent Mobility Dynamics of FcγRIIA Facilitates Platelet Haptotaxis and Capture of Opsonized Bacteria
by: Raghavendra Palankar, et al.
Published: (2022-05-01)

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase
by: Rundan Duan, et al.
Published: (2021-12-01)

Bruton’s Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia
by: Leigh Naylor-Adamson, et al.
Published: (2021-11-01)

Genetic variation of FcγRIIa induces higher uptake of Leishmania infantum and modulates cytokine production by adherent mononuclear cells in vitro
by: Jonatas da Silva Catarino, et al.
Published: (2024-02-01)

IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism
by: Rui Duan, et al.
Published: (2023-03-01)

CLEC18A Impairs Phagocytosis by Reducing FcγRIIA Expression and Arresting Autophagosome-Lysosome Fusion
by: Tsai-Ling Liao, et al.
Published: (2023-06-01)

Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
by: Christoph Gstöttner, et al.
Published: (2022-09-01)

Corrigendum: FcγRIIa—dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparininduced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation
by: Mustapha Abdelouahed, et al.
Published: (2023-12-01)

FcγRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation
by: Mustapha Abdelouahed, et al.
Published: (2023-11-01)

Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet Reactivity
by: David J. Schneider, et al.
Published: (2022-05-01)

Imaging Patterns of Recurrent Infarction in the Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD) Study
by: Rajbeer S. Sangha, et al.
Published: (2021-01-01)

CD32a polymorphism rs1801274 affects the risk of Kawasaki disease
by: Zhiyong Wang, et al.
Published: (2020-01-01)

Role of platelets and megakaryocytes in adaptive immunity
by: Genevieve Marcoux, et al.
Published: (2021-04-01)

Role of platelets and platelet receptors in cancer metastasis
by: Martin Schlesinger
Published: (2018-10-01)

Computational Fluid Dynamics in Intracranial Atherosclerotic Disease
by: Ahmad A. Ballout, et al.
Published: (2024-01-01)

Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis
by: Xinyi Leng, et al.
Published: (2021-10-01)

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
by: Jessica C. Anania, et al.
Published: (2018-08-01)

Precision Medicine for Intracranial Atherosclerotic Disease
by: David S. Liebeskind
Published: (2021-02-01)

Chemotropic signaling by BMP7 requires selective interaction at a key residue in ActRIIA
by: Jeanette C. Perron, et al.
Published: (2019-07-01)

FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia
by: Marwa Zakaria, et al.
Published: (2023-01-01)

Editorial: Intracranial atherosclerotic disease: epidemiology, imaging, treatment and prognosis, volume II
by: Xinyi Leng, et al.
Published: (2023-11-01)

Versatile Endogenous Editing of GluRIIA in <i>Drosophila melanogaster</i>
by: Constantin J. Beckers, et al.
Published: (2024-02-01)

Recurrent stroke risk in intracranial atherosclerotic disease
by: Ahmad A. Ballout, et al.
Published: (2022-09-01)

CD32a receptor in health and disease
by: N. A. Arsentieva, et al.
Published: (2020-05-01)

Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
by: Javier Durán, et al.
Published: (2018-04-01)

Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months
by: Samantha J. Montague, et al.
Published: (2022-03-01)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
by: Fabian Bohländer, et al.
Published: (2021-06-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Endovascular treatment of symptomatic intracranial atherosclerotic disease
by: Syed I Hussain
Published: (2011-02-01)

Implication of VDR rs7975232 and FCGR2A rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population
by: Mestiri S, et al.
Published: (2020-08-01)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
by: Céline Monnet, et al.
Published: (2021-08-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)